NANOG and cancer: The in vivo administration of EGCG also shows the reduction of cancer growth and the levels of stemness factors, such as SRY-box transcription factor 2 (SOX2), Octamer-binding protein 4 (OCT4), and Nanog homeobox (NANOG) [151] (Figure 2 and Table 4).